Clinical Trial

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity...

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping

ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference

Multiple datasets support continued development of ProMIS’ antibody therapeutics and vaccines that selectively target toxic misfolded proteins to treat neurodegenerative...

Hospital Information Systems Market worth US$116.75 billion by 2030 with 10.6% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., March 21, 2025 /PRNewswire/ -- The global Hospital Information Systems Market, valued at US$58.13 billion in 2023, is...

Paradigm Health Announces Oncology and Healthcare Expert Dr. Karen E. Knudsen Appointed to Board of Directors and Launch of New AI-Driven Solution for Clinical Trial Data Collection and Management

COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ -- Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of...

error: Content is protected !!